In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 0.19 below Harvard Bioscience Inc average.

Within Laboratory Analytical Instruments industry 17 other companies have achieved higher Quick Ratio than Harvard Bioscience Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 2431 to 3172.

Explain Quick Ratio?
How much Cash & cash equivalents HBIO�s has?
What are HBIO�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/HBIO/financial-strength

https://api.csimarket.com/api/v1/companies/HBIO/fundamentals

https://api.csimarket.com/api/v1/companies/HBIO/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

HBIO Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3
Y / Y Current Liabilities Change	-49.28 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-28.77 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	0.19	Subscribe	Subscribe	Subscribe	Subscribe
HBIO's Total Ranking	# 3172	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	5.38 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	-25.33 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 18
Healthcare Sector	# 800
Overall Market	# 3172

Quick Ratio Statistics
High	Average	Low
3.15	0.69	0.08
(Dec 31 2010)		(Dec 31 2024)

Financial Statements
Harvard Bioscience Inc 's Current Liabilities	$ 26 Millions	Visit HBIO's Balance sheet
Harvard Bioscience Inc 's Cash & cash equivalent	$ 5 Millions	Visit HBIO's Balance sheet
Source of HBIO's Sales		Visit HBIO's Sales by Geography

Cumulative Harvard Bioscience Inc 's Quick Ratio

HBIO's Quick Ratio for the trailling 12 Months

HBIO Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-56.68 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	13.21 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	0.3	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 4089	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	-22.07 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-6.75 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to HBIO Financial Strength Comparisons >> Go to Compare HBIO Quick Ratio to its Competitors

On the trailing twelve months basis Current Liabilities decreased faster than Harvard Bioscience Inc 's average Cash & cash equivalent, this led to increase in in Harvard Bioscience Inc 's Quick Ratio to 0.3, Quick Ratio remained below HBIO average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 22 other companies have achieved higher Quick Ratio than Harvard Bioscience Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 2930 to 4089.

Explain Quick Ratio?
How much Cash & cash equivalents HBIO�s has?
What are HBIO�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Laboratory Analytical Instruments Industry	# 23
Healthcare Sector	# 908
Within the Market	# 4089

trailing twelve months Quick Ratio Statistics
High	Average	Low
2.18	0.59	0.11
(Sep 30 2013)		(Sep 30 2025)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Laboratory Analytical Instruments Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Avantor Inc	0.34	$ 464.300 Millions	$ 1,369.000 Millions
Waters Corporation	0.27	$ 593.000 Millions	$ 2,180.000 Millions
Harvard Bioscience Inc	0.19	$ 4.856 Millions	$ 26.127 Millions
Bruker Corporation	0.13	$ 148.100 Millions	$ 1,172.100 Millions
BIOFORCE NANOSCIENCES HOLDINGS, INC.	0.11	$ 0.032 Millions	$ 0.277 Millions
Mettler toledo International Inc	0.04	$ 52.237 Millions	$ 1,250.307 Millions
Illumina Inc	0.04	$ 48.000 Millions	$ 1,285.000 Millions

Date modified: 2026-11-11T13:45:50+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.